Automation can be the answer for future growth in the
pharmaceutical manufacturing sectors, suggests an industry
analysis.
Faced with tighter margins and regulatory issues, automation
and software improvements can help pharmaceutical manufacturers
produce drugs at a lower cost and at a faster pace, according
to Frost & Sullivan’s “Strategic Analysis
of the Automation and Software Solutions in the World
Pharmaceutical Markets.”
“The gradual exit of blockbuster drugs and the
introduction of generic ones have increased the pressure
on profit margins, compelling manufacturers to produce
specialized potent drugs that are difficult to replicate
and need to be produced in smaller quantities,” notes
Sanjeev R. Sridharan, Frost & Sullivan Research Analyst. “As
this necessitates the production of multiple products
on the same equipment, companies are increasingly employing
automation and software solutions.
“The key success factor for automation companies
is to establish long-term partnership with pharmaceutical
customers,” said Sanjeev. “Even as pharmaceutical
customers look for standardization, automation companies
need to grow aggressively with their customers as they
expand globally.”
RSI - Executive Search Firm News | Executive & Candidate
Resources for the Executive Search Recruiting Industry
Current Location: Executive Search Firm Industry Articles - Automation Key To Pharmaceutical Growth
Search Solutions
RSI's Executive Search
Process will find the best Candidate for your position.
RSI's Executive Recruiting
Experts bring Employers only the best Executive talent.